Medtronic (MDT) Asset Writedowns and Impairment (2014 - 2026)

Medtronic has disclosed Asset Writedowns and Impairment across 13 years of filings, most recently posting $25.0 million for Q3 2026.

• In Q3 2026, Asset Writedowns and Impairment fell 10.71% year-over-year to $25.0 million; the TTM figure through Jul 2026 stood at $133.0 million (changed 0.0% YoY), while the FY2026 annual figure was $136.0 million, up 10.57% from the prior year.
• Asset Writedowns and Impairment came in at $25.0 million for Q3 2026 at Medtronic, down from $34.0 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $309.0 million in Q2 2024 to a low of $13.0 million in Q1 2023.
• Average Asset Writedowns and Impairment over 5 years is $42.8 million, with a median of $26.0 million recorded in 2022.
• Year-over-year, Asset Writedowns and Impairment plunged 97.09% in 2022 and jumped 1526.32% in 2024.
• Over 5 years, Asset Writedowns and Impairment stood at $26.0 million in 2022, then plunged by 38.46% to $16.0 million in 2023, then surged by 68.75% to $27.0 million in 2024, then surged by 40.74% to $38.0 million in 2025, then plunged by 34.21% to $25.0 million in 2026.
• Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $25.0 million in Q3 2026, $34.0 million in Q2 2026, and $36.0 million in Q1 2026.